Phoenix Rising Companies Announces Definitive MOU To Acquire High Tech Medical Products Distribution Company
Phoenix Rising Companies Announces Definitive MOU To Acquire High Tech Medical Products Distribution Company
PARK CITY, UT / ACCESSWIRE / February 28, 2022 / Phoenix Rising Companies (OTCQB:PRCX):
德克薩斯州帕克城/ACCESSWIRE/2022年2月28日/鳳凰新興公司(場外交易代碼:PRCX):
DS Chang, CEO and Chairman of the company is pleased to announce the completion of a definitive MOU to acquire 100% ownership of Emvera Technologies, LLC, based in the greater Atlanta area.
公司首席執行官兼董事長DS Chang高興地宣佈,收購總部位於大亞特蘭大地區的Emvera Technologies,LLC的最終諒解備忘錄已經完成。
Founded in 2012, Emvera is focused on distributing various lines of aesthetic medical devices, including state-of- the-art lasers and energy-based systems.
Emvera成立於2012年,專注於分銷各種美容醫療設備系列,包括最先進的激光和基於能量的系統。
The market for aesthetic or "vanity" treatments is growing steadily year over year. According to Grandview Research, the US market size in 2021 was $53.8 Billion USD, with a predicted compound annual growth rate of 15.2% annually through at least 2030.
美容或“虛榮心”治療的市場每年都在穩步增長。根據Grandview Research的數據,2021年美國市場規模為538億美元,預計至少到2030年,年複合增長率為15.2%。
Emvera's customers include doctors, medical professionals and aesthetic practitioners who
Emvera的客户包括醫生、醫療專業人員和美容從業者
acquire the devices for use in a variety of treatments such as skin resurfacing, skin renewal and hair removal.
購買這些設備,以用於各種治療,如皮膚表面重塑、皮膚更新和脱毛。
Emvera offers attractive financing options for their customers, with industry-leading transferable warranties, trade-in programs and reasonably priced consumables.
Emvera為他們的客户提供有吸引力的融資選擇,擁有業界領先的可轉讓保修、以舊換新計劃和價格合理的消費品。
Following years of profitable operations, the worldwide pandemic had a negative impact on Emvera's business for the prior two years. However, this has also created opportunities for Emvera, including pending strategic alliances which it has been pursing during the last six months. In addition, sales and activity in the industry are starting to return to pre-pandemic levels.
在多年的盈利運營之後,全球大流行對Emvera前兩年的業務產生了負面影響。然而,這也為Emvera創造了機會,包括過去6個月來一直在尋求的懸而未決的戰略聯盟。此外,該行業的銷售和活動正開始恢復到大流行前的水平。
Emvera's CEO is Eric Fuller, a long-time advisor to Phoenix and its Vice President of U.S. sales, with over 20 years of experience, and well known for his integrity and expertise.
Emvera的首席執行官是埃裏克·富勒(Eric Fuller),他是菲尼克斯公司的長期顧問,也是鳳凰公司負責美國銷售的副總裁,擁有20多年的經驗,以正直和專業知識而聞名。
The MOU calls for a host of additional steps, including the issuance of about 46 million common restricted shares of Phoenix and creation of financing for Emvera operations
諒解備忘錄要求採取一系列額外措施,包括髮行約4600萬股鳳凰衞視的普通股限制性股票,併為Emvera業務創造融資
pursuant to a formal acquisition agreement in the next 90 days.
根據一項正式的收購協議,在接下來的90天內。
In addition to this MOU, Phoenix continues to press forward with R&D projects and additional acquisitions, with an eye towards developing Western hemisphere subsidiaries and divisions which hold the promise growth, sustainability and profitability.
除了這份諒解備忘錄外,菲尼克斯還將繼續推進研發項目和其他收購,着眼於發展具有增長、可持續性和盈利前景的西半球子公司和部門。
Interested parties can learn more about Emvera by visiting
感興趣的人可以通過訪問以下網站了解更多關於Emvera的信息
Additional information will be announced as it becomes available.
更多信息將在可用時公佈。
For information on Phoenix Rising Companies visit
有關鳳凰崛起公司的信息,請訪問
contact ir@phoenix-cos.com
聯繫ir@Phoenix-cos.com
CAUTIONARY STATEMENT
警示聲明
This press release contains forward-looking statements. Known and unknown risks may cause actual future results to vary widely. The statements are based upon Management's and Advisor's current expectations, estimates and projections; are not guarantees of future performance and are subject to certain risks and uncertainties and other factors, some of which are beyond Management's control and are difficult to predict. A reader of this press release should not place undue reliance on forward-looking statements. Investors should understand investing in shares of RSSV involves a high degree of risk and should seek competent investment advice prior to purchasing shares.
本新聞稿包含前瞻性陳述。已知和未知的風險可能會導致未來的實際結果大相徑庭。這些陳述是基於管理層和顧問公司目前的預期、估計和預測;不是對未來業績的保證,會受到某些風險、不確定因素和其他因素的影響,其中一些因素是管理層無法控制的,很難預測。本新聞稿的讀者不應過分依賴前瞻性陳述。投資者應該明白投資RSSV的股票涉及高度風險,在購買股票之前應該尋求稱職的投資建議。
SOURCE: Phoenix Rising Companies
資料來源:鳳凰新秀公司